Endocrine Abnormalities in Thalassemia

Annals of the New York Academy of Sciences

Volumn 612, Issue 1, 1990, Pages 293-310

  VULLO, C ^a   DE SANCTIS, V ^a   KATZ, M ^b   WONKE, B ^c   HOFFBRAND, A V ^d   BAGNI, B ^a   TORRESANI, T ^e   TOLIS, G ^f   MASIERO, M ^g   DI PALMA, A ^a   BORGATTI, L ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b Middlesex Medical School ^*  (United Kingdom)

^c WHITTINGTON HOSPITAL   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f HIPPOKRATION HOSPITAL   (Greece)

^g UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENAL FUNCTION; CONFERENCE PAPER; DELAYED PUBERTY; FEMALE; HUMAN; HYPOGONADISM; HYPOPARATHYROIDISM; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; SPERMATOGENESIS; THALASSEMIA;

ADOLESCENT; DIABETES MELLITUS, INSULIN-DEPENDENT; ENDOCRINE DISEASES; FEMALE; HUMAN; MALE; PUBERTY; THALASSEMIA;

EID: 0025569761     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1990.tb24317.x     Document Type: Article

References (46)

1. Thalassemia intermedia with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria
2. Endocrine function in thalassemia major
3. Endocrine function in thalassemia major
4. Hormonal changes in thalassemia major
5. Problems related to treatment of beta‐thalassemia major
6. A new approach to the transfusion management of thalassemia
7. Insulin dependent diabetes mellitus in thalassemia
8. Abnormal glucose tolerance in β‐thalassemia major
9. The development of diabetes mellitus and chronic liver disease in long‐term chelated β‐thalassemic patients
10. Islet‐cell‐surface antibodies in subjects with β‐thalassemia major affected by diabetes mellitus
11. Insulin resistance in cirrhosis: Evidence for a postreceptor defect
12. Insulin resistance and iron overload
13. Glucose intolerance in liver cirrhosis
14. A study of beta‐cell function after glucagon stimulation in thalassemia major treated by high transfusion programme
15. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion
16. Studio fluorangiografico in pazienti affetti da morbo di Cooley e diabete
17. Diabetic vascular changes in children
18. Prevalence and development of retinopathy in children and adolescents with type‐1 (insulin dependent) diabetes mellitus: A longitudinal study
19. Plasma lipids and lipoproteines pattern in beta thalassemia major
20. Kidney disease associated with diabetes
21. Microalbuminuria as a predictor of clinical nephropathy in insulin dependent diabetes mellitus
22. Endocrine involvement in children with p‐thalassemia major: Transverse and longitudinal studies. I. Pituitary‐thyroidal axis function and its correlation with serum ferritin levels
23. Primary hypothyroidism and the low T, syndrome in thalassemia major
24. Impaired parathyroid response induced hypocalcemia in thalassemia major
25. Parathyroid hormone, calcitonin and vitamin D metabolites in beta‐thalassemia major
26. Endocrine functioning in multitransfused prepubertal patients with homozygous β‐thalassemia
27. Serum 1,25‐dihydroxyvitamin D and osteocalcin concentrations in thalassemia major
28. Bone disease in children with homozygous β‐thalassemia
29. Growth and sexual maturation in thalassemia major
30. Il destino dei pazienti affetti da talassemia major
31. Gonadal function in patients with β‐thalassemia major
32. Hypothalamic‐pituitary‐gonadal axis in thalassemic patients with secondary amenorrhea
33. Induction of ovulation in a thalassemic patient
34. Sexual performance and fertility potential in patientswith beta thalassemia major
35. Semen parameters in patients with homozygous beta‐thalassemia
36. Assessment of hypogonadism in patients affected by thalassemia major
37. Induction of spermatogenesis in thalassemia
38. Effect of human chorionic gonadotropin on growth velocity and biological growth parameters in adolescents with thalassemia major
39. Endocrine evaluation in thalassemia major
40. Normal growth hormone (GH) response to GH‐releasing hormone in children with thalassemia major before puberty: A possible age‐related effect
41. Impaired growth hormone response to GH releasing hormone in thalassemia major
42. Measurement of nocturnal urinary growth hormone values
43. Endocrine abnormalities in thalassemia major
44. Adrenal function in thalassemia major following long‐term treatment with multiple transfusions and chelation therapy: Evidence for dissociation of cortisol and adrenal androgen secretion. Am. J. Dis
45. Gap in doctor‐patients communication
46. Postmenopausal estrogen replacement and breast cancer